Cytosorbents Ownership | Who Owns Cytosorbents?


OverviewRevenueFinancialsChartTranscripts

Cytosorbents Ownership Summary


Cytosorbents is owned by 30.17% institutional investors, 3.82% insiders, and 66.01% retail investors. Avenir is the largest institutional shareholder, holding 5.47% of CTSO shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.37% of its assets in Cytosorbents shares.

CTSO Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockCytosorbents30.17%3.82%66.01%
SectorHealthcare Stocks 88.01%8.90%3.09%
IndustryMedical Device Stocks76.80%8.19%15.00%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Avenir2.97M5.47%$2.09M
Skylands capital2.78M5.11%$2.53M
Granahan investment management2.66M4.91%$1.87M
Vanguard group1.95M3.59%$1.37M
Neuberger berman group1.54M2.83%$1.08M
Sargent investment group1.25M2.29%$1.31M
Cm management700.00K1.29%$637.00K
Blackrock655.80K1.21%$461.03K
Blackrock funding, inc. /de627.30K1.15%$570.85K
Geode capital management434.64K0.80%$305.62K

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Cm management700.00K0.57%$637.00K
Skylands capital2.78M0.35%$2.53M
Sargent investment group1.25M0.21%$1.31M
Avenir2.97M0.20%$2.09M
Granahan investment management2.66M0.07%$1.87M
Seelaus asset management18.80K0.02%$17.11K
Key client fiduciary advisors34.56K0.01%$31.45K
Texas capital bank wealth management services23.17K0.00%$16.29K
Atomi financial group27.44K0.00%$24.97K
Country club bank /gfn15.22K0.00%$13.70K

Top Buyers

HolderShares% AssetsChange
Raymond james financial108.62K-108.62K
Susquehanna group, llp89.79K-73.59K
Kestra advisory services55.00K0.00%41.80K
Ep wealth advisors28.00K0.00%28.00K
Skylands capital2.78M0.35%26.20K

Top Sellers

HolderShares% AssetsChange
Granahan investment management2.66M0.07%-381.02K
Sargent investment group1.25M0.21%-377.38K
Neuberger berman group1.54M0.00%-376.05K
Avenir2.97M0.20%-202.43K
Cm management700.00K0.57%-100.00K

New Positions

HolderShares% AssetsChangeValue
Raymond james financial108.62K-108.62K$98.84K
Ep wealth advisors28.00K0.00%28.00K$19.68K
New wave wealth advisors1.63K0.00%1.63K$1.48K
Citadel advisors500.00-500.00$352.00
Fmr285.00-285.00$200.00

Sold Out

HolderChange
Qube research-1.00
Allworth financial lp-37.00
Lazard asset management-1.09K
Soa wealth advisors, llc.-2.22K
Bank of new york mellon-3.64K

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Sep 30, 2024538.16%16,427,732-1.05%303.22%1754.55%13-23.53%
Jun 30, 2024494.26%16,601,658-5.30%301.99%11-21.43%1713.33%
Mar 31, 202447-7.84%17,531,124-2.28%392.40%14-30.00%157.14%
Dec 31, 202351-5.56%17,940,75818.13%403.40%2011.11%14-12.50%
Sep 30, 202354-8.47%15,187,9430.02%342.85%18-33.33%1645.45%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard Total Stock Mkt Idx Inv1.30M2.37%-
M&G (ACS) Granahan US Sm Cp Gr GBPZ1AAcc763.50K1.40%-101.78K
Neuberger Berman Intrinsic Value I726.14K1.32%-
Vanguard Institutional Extnd Mkt Idx Tr568.23K1.03%-
JNL Multi-Manager Small Cap Growth A435.56K0.71%-103.92K
Fidelity Extended Market Index255.93K0.42%-2.06K
Extended Equity Market Fund K203.96K0.37%100.57K
Victory Small Cap Stock188.18K0.34%-150.71K
Granahan Inv Mgt Sm-Cap Core Gr188.18K0.31%-150.19K
Granahan Small Cap Select132.41K0.22%-22.59K

Recent Insider Transactions


DateNameRoleActivityValue
Dec 13, 2024MARIANI PETER J Chief Financial OfficerBuy$19.29K
Dec 12, 2024MARIANI PETER J Chief Financial OfficerBuy$17.87K
Dec 11, 2024MARIANI PETER J Chief Financial OfficerBuy$10.10K
Dec 13, 2023Sobel Alan D.-Buy$30.00K
Dec 13, 2023Sobel Alan D.-Buy$15.79K

Insider Transactions Trends


DateBuySell
2024 Q42-
2024 Q3--
2024 Q2--
2024 Q1--
2023 Q416-

CTSO Ownership FAQ


Who Owns Cytosorbents?

Cytosorbents shareholders are primarily institutional investors at 30.17%, followed by 3.82% insiders and 66.01% retail investors. The average institutional ownership in Cytosorbents's industry, Medical Device Stocks, is 76.80%, which Cytosorbents falls below.

Who owns the most shares of Cytosorbents?

Cytosorbents’s largest shareholders are Avenir (2.97M shares, 5.47%), Skylands capital (2.78M shares, 5.11%), and Granahan investment management (2.66M shares, 4.91%). Together, they hold 15.49% of Cytosorbents’s total shares outstanding.

Does Blackrock own Cytosorbents?

Yes, BlackRock owns 1.21% of Cytosorbents, totaling 655.8K shares as of Jun 2024. This represents 0% of BlackRock's total assets, with a market value of 461.03K$. In the last quarter, BlackRock decreased its holdings by -66.63K shares, a -9.22% change.

Who is Cytosorbents’s biggest shareholder by percentage of total assets invested?

Cm management is Cytosorbents’s biggest shareholder by percentage of total assets invested, with 0.57% of its assets in 700K Cytosorbents shares, valued at 637K$.

Who is the top mutual fund holder of Cytosorbents shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Cytosorbents shares, with 2.37% of its total shares outstanding invested in 1.3M Cytosorbents shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools